This content is from: Premium
Hedge Funds Eye Two IPOs
The market for health care company public offerings is ready to take off again.
The IPO market is starting to heat up again.And while no unicorns have filed to go public, at least two healthcare and biopharma companies with hedge fund investors priced their deals earlier this week.For example, Black Diamond Therapeutics said in a regulatory filing that it plans to offer 8.9 million
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.